Thoracic 23

Criteria for achieving an R0 resection of Stage III NSCLC include all of the following except:

Endobronchial ultrasound (EBUS) with transbronchial needle aspiration (TBNA) has the advantage of reaching which lymph node stations traditional cervical mediastinoscopy cannot?

8. Which of the following is true regarding adjuvant therapy for patients with early stage lung cancer?

What risk factors favor a recommendation for consideration of adjuvant chemotherapy for resected early-stage NSCLC

According to the 2020 NCCN guidelines, what is the recommendation for lymph node sampling at the time of lung resection for Stage I and II NSCLC?

Which of the following is not recommended by NCCN guidelines in the pretreatment evaluation of clinical Stage IA NSCLC

Which of the following has the greatest prognostic impact on malignant potential?

15. A 75 male former heavy smoker is found incidentally to have a solid 7 mm nodule in the lingula of the left lung. If the first scan shows staiblity of the lesion, no further follow-up imaging is recommended.

The ACOSOG Z0030 trial demonstrated increased survival with mediastinal lymph node dissection for patients with early stage NSCLC and negative mediastinal and hilar nodes

A 75 male former heavy smoker is found incidentally to have a solid 7 mm nodule in the lingula of the left lung. Which is the appropriate first interval for re-imaging?

High risk features of a solitary pulmonary nodule include each of the following except

Current (2020) NCCN guidelines for lung cancer screening include all of the following EXCEPT

Which of the following has NOT been suggested to be a potential harm of lung cancer screening

Which of the following is true

In which of the following scenarios is annual lung cancer screening with a low-dose CT scan indicated according to the National Comprehensive Cancer Network (NCCN) screening criteria

Cervical mediastinoscopy is capable of accessing which set of nodal stations?

EBUS is capable of accessing which set of nodal stations?

A patient is diagnosed with a 5.4 cm lung adenocarcinoma in the right lower lobe. Staging workup reveals a clinical T3N0M0 tumor. The patient is taken to the operating room for lobectomy. At the time of surgery, the tumor is noted to be invading the diaphragm. The diaphragm is resected en bloc with the lung. The final pathology confirms tumor invasion into the diaphragm and notes a positive level 11R lymph node. What is this patient’s pathologic stage

A patient is diagnosed with a 2.4 cm biopsy-proven adenocarcinoma of the left upper lobe. There is a second nodule in the left upper lobe measuring 1.2 cm that is suspicious for lung cancer. Staging workup shows no evidence of lymph node or distant metastasis. The patient undergoes a left upper lobectomy. On review of the pathology, both masses were moderately differentiated squamous cell carcinoma. None of the lymph nodes were positive. What is this patient’s pathologic stage?

5. A patient is found to have a 5 mm part-solid nodule in the periphery of the right lower lobe that was identified incidentally on a CT scan performed after the patient was involved in a motor vehicle collision. The lesion is followed over time and grows to 1 cm over a 6-month interval. It is suspicious for lung cancer. A level 4R lymph node measures 1.2 cm in the short axis. PET-CT shows the nodule has an SUV max of 3.8. There are no FDG-avid lymph nodes. A transthoracic biopsy of the nodule reveals adenocarcinoma. FEV1 is 95% predicted and DLCO is 87% predicted. What is the next step in management?